ScoreWhy is Axsome Therapeutics, Inc. ?
1
With a growth in Net Sales of 23.53%, the company declared Very Positive results in Jun 25
- NET SALES(Q) Highest at USD 150.04 MM
- RAW MATERIAL COST(Y) Fallen by -1.13% (YoY)
- OPERATING PROFIT(Q) Highest at USD -42.69 MM
2
High Institutional Holdings at 91.95%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
- Their stake has increased by 2.34% over the previous quarter.
3
Market Beating performance in long term as well as near term
- Along with generating 54.22% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Axsome Therapeutics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Axsome Therapeutics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Axsome Therapeutics, Inc.
47.32%
2.46
44.47%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
246.02%
EBIT Growth (5y)
-174.05%
EBIT to Interest (avg)
-26.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.20
Sales to Capital Employed (avg)
1.04
Tax Ratio
0.03%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
91.95%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
103.56
EV to EBIT
-22.54
EV to EBITDA
-23.34
EV to Capital Employed
-84.19
EV to Sales
12.48
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-464.66%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend21What is working for the Company
NET SALES(Q)
Highest at USD 150.04 MM
RAW MATERIAL COST(Y)
Fallen by -1.13% (YoY
OPERATING PROFIT(Q)
Highest at USD -42.69 MM
OPERATING PROFIT MARGIN(Q)
Highest at -28.45 %
PRE-TAX PROFIT(Q)
Highest at USD -46.65 MM
NET PROFIT(Q)
Highest at USD -45.69 MM
EPS(Q)
Highest at USD -0.97
-6What is not working for the Company
INTEREST(9M)
At USD 16.3 MM has Grown at 56.07%
ROCE(HY)
Lowest at -280.68%
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.1 times
Here's what is working for Axsome Therapeutics, Inc.
Net Sales
Highest at USD 150.04 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Net Sales
At USD 150.04 MM has Grown at 38.88%
over average net sales of the previous four periods of USD 108.04 MMMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Operating Profit
Highest at USD -42.69 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at -28.45 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at USD -46.65 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -45.69 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
EPS
Highest at USD -0.97
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Raw Material Cost
Fallen by -1.13% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Axsome Therapeutics, Inc.
Interest
At USD 16.3 MM has Grown at 56.07%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Debtors Turnover Ratio
Lowest at 3.1 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
